SearchDictionaryMobileLogin

Daniel J Rader Selected Research

Atherosclerosis (Atheroma)

07/2008CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice.
10/2007'Multipurpose oxidase' in atherogenesis.
01/2007Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.
01/2007Plasma cytokines, metabolic syndrome, and atherosclerosis in humans.
08/2006Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8.
05/2006Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?
12/200512/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathway.
10/2005Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
04/2005Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?
02/2005Resistin is an inflammatory marker of atherosclerosis in humans.
11/2003High-density lipoproteins as an emerging therapeutic target for atherosclerosis.
10/2003Genetics of increased HDL cholesterol levels: insights into the relationship between HDL metabolism and atherosclerosis.
10/2003Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
02/2003Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
11/2002Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
10/2002High-density lipoproteins and atherosclerosis.
09/2002Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia.

Articles by Research Topic

Disease

17Atherosclerosis (Atheroma)
07/2008 - 09/2002
7Inflammation
02/2008 - 07/2002
5Coronary Artery Disease (Coronary Atherosclerosis)
02/2006 - 03/2003
4Syndrome
01/2007 - 01/2006
3Hypercholesterolemia
08/2008 - 08/2003
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2007 - 09/2002
2Obesity
09/2004 - 05/2003
1Abdominal Aortic Aneurysm
03/2008
1Coronary Disease (Coronary Heart Disease)
06/2006
1Tissue Adhesions
03/2006
1Myocardial Infarction
01/2006
1Aortic Aneurysm (Aneurysm, Aortic)
09/2004
1Hyperlipidemias (Hyperlipidemia)
09/2004
1Hypertriglyceridemia
03/2004
1Thrombosis (Thrombus)
01/2002

Drug/Important Bio-Agent (IBA)

5Lipase (Acid Lipase)IBA
02/2008 - 07/2004
5Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2007 - 07/2002
5Lipoproteins (Lipoprotein)IBA
03/2006 - 07/2004
4CholesterolIBA
05/2006 - 11/2002
3ApolipoproteinsIBA
06/2006 - 03/2003
3HDL CholesterolIBA
03/2006 - 07/2002
3HDL LipoproteinsIBA
11/2003 - 01/2002
2microsomal triglyceride transfer proteinIBA
08/2008 - 01/2007
2Apolipoproteins E (ApoE)IBA
07/2008 - 08/2006
2AdipokinesIBA
03/2006 - 01/2006
2Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
12/2005 - 09/2002
2C-Reactive ProteinIBA
09/2004 - 10/2003
2Cholesterol Ester Transfer ProteinsIBA
09/2004 - 02/2003
2rosuvastatin (Crestor)FDA Link
03/2004 - 03/2003
2LDL Receptors (LDL Receptor)IBA
10/2003 - 11/2002
1ezetimibe (Zetia)FDA Link
08/2008
1Angiotensin IIIBA
03/2008
1prostaglandin-E synthaseIBA
03/2008
1OxidoreductasesIBA
10/2007
1CytokinesIBA
01/2007
1PPAR alphaIBA
03/2006
1LipidsIBA
03/2006
1rosiglitazone (Avandia)FDA Link
03/2006
1Carrier Proteins (Binding Protein)IBA
02/2006
1leukotriene A4 hydrolaseIBA
01/2006
1pioglitazone (Actos)FDA Link
01/2006
1Vitamin EFDA Link
12/2005
1ResistinIBA
02/2005
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
09/2004
1LeptinIBA
08/2004
1guggulu extractIBA
08/2003
1Cholesterol Esters (Cholesteryl Esters)IBA
08/2003
1Pravastatin (Pravachol)FDA LinkGeneric
03/2003
1atorvastatin (Lipitor)FDA Link
03/2003
1Simvastatin (Zocor)FDA LinkGeneric
03/2003
1Interleukin-12 (IL 12)IBA
09/2002
1Secretory Phospholipases A2IBA
07/2002

Therapy/Procedure

2Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
09/2004 - 05/2003
1Blood Component Removal (Apheresis)
12/2005